Key Statistics
Market Cap$138.33M
P/E Ratio2.3
Div. Yield—
EPS (TTM)$1.50
52W High$3.76
52W Low$1.70
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+3.32%
3 Month+15.54%
1 Year+58.33%
FinancialsAnnual · QuiverQuant
Revenue$1.34M
Assets$220.55M
Liabilities$57.66M
Net Income$5.09M
About
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for the administration of polypeptides. The company is headquartered in New York, New York.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ORMP with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.